NasdaqGM - Delayed Quote USD

Maze Therapeutics, Inc. (MAZE)

Compare
12.79
+0.79
+(6.58%)
At close: February 18 at 4:00:00 PM EST

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
HOMCY CHARLES J Director Conversion of Exercise of derivative security Feb 3, 2025 --
LIM JONATHAN E Director Conversion of Exercise of derivative security Feb 3, 2025 --
THIRD ROCK VENTURES IV, L.P. Beneficial Owner of more than 10% of a Class of Security Conversion of Exercise of derivative security Feb 3, 2025 --

Related Tickers